| Authors: |
Baker GA; International Bureau for Epilepsy, 1015 15th Street, NW Suite 1000, Washington, DC 20005, United States. Electronic address: g.baker@liverpool.ac.uk., Brodie M; School of Medicine, Dentistry & Nursing, University of Glasgow, Glasgow, United Kingdom. Electronic address: martinbrodie@ibe-epilepsy.org., Davies E; International Bureau for Epilepsy, 1015 15th Street, NW Suite 1000, Washington, DC 20005, United States., Jedrzejczak J; Department of Neurology and Epileptology, Centre of Postgraduate Medical Education, Warsaw, Poland. Electronic address: jjedrzejczak@cmkp.edu.pl., Lally L; University College Dublin, Belfield, Dublin 4, Ireland., Mifsud J; Department of Clinical Pharmacology and Therapeutics, Faculty of Medicine and Surgery, University of Malta, Msida, Malta. Electronic address: janet.mifsud@um.edu.mt., Mostacci B; Istituto delle Scienze Neurologiche di Bologna, Full member of the ERN EpiCARE, Bologna, Italy. Electronic address: barbara.mostacci@isnb.it., Okujava N; Tbilisi State Medical University, Tbilisi, Georgia; SEIN-SKUH Epilepsy and Sleep Centre, Tbilisi, Georgia. Electronic address: n.okujava@tsmu.edu., Sofia F; International Bureau for Epilepsy, 1015 15th Street, NW Suite 1000, Washington, DC 20005, United States. Electronic address: francescasofia@ibe-epilepsy.org., Winterbottom J; The Walton Centre NHS Foundation Trust, Liverpool, United Kingdom. Electronic address: janine.winterbottom@nhs.net., Wollscheid L; Epilepsie Empowerment Deutschland e.V., Kaiserstrasse 217, 76133 Karlsruhe, Germany. |
